|
| |
BioPortfolio's Approved Drugs DatabaseNamendaMemantine HydrochlorideDownload PDF containing detailed information.
Press Releases About Namenda:
|
 |
| Reportlinker Adds World Neurodegenerative Diseases Market 2009-2024 |
3rd November, 2009 |
Reportlinker |
-- Rilutek.
In our pipeline analyses we include emerging therapeutics such as stem cells, gene therapy and monoclonal antibodies, among other prominent developments.
Detailed analysis of the
|
| Forest Laboratories, Inc. Reports Fiscal Year 2009 Fourth Quarter Reported EPS of $0.31 Including $0.45 Per Share Charge Related to the Ongoing United States Attorney's Office Investigation |
21st April, 2009 |
Forest Laboratories, Inc. |
Company Provides Fiscal Year 2010 EPS Guidance in the Range of $3.45-$3.55 Per Share
NEW YORK, April 21 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX), a U.S.-based pharmaceutical
|
| Forest Laboratories, Inc. Reports Q3'09 Diluted Earnings Per Share of $0.62, Including $0.41 Per Share Charge for New Product Licensing Fees |
20th January, 2009 |
Forest Laboratories, Inc. |
NEW YORK, Jan. 20, 2009 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX), a U.S. based pharmaceutical company, today announced that reported diluted earnings per share equaled $0.62 in
|
| Forest Laboratories, Inc. Reports Fiscal Second Quarter 2009 Earnings per Share of $0.80 |
21st October, 2008 |
Forest Laboratories, Inc. |
NEW YORK, Oct. 21 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX), an international pharmaceutical manufacturer and marketer, today announced that fully diluted earnings per share
|
| New Data Highlight Positive Results of Namenda(R) (memantine HCl) Once-Daily Extended-Release Formulation |
30th July, 2008 |
Forest Laboratories, Inc. |
CHICAGO, July 30 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc.
(NYSE: FRX) presented today positive Phase III data of a once-daily
extended-release formulation of Namenda(R) (memantine HCl)
|
This page has been viewed 34 times
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Namenda across BioPortfolio, or for Namenda Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
